Magalhães J, Rosa B, Cotter J. Endoscopic retrograde cholangiopancreatography for suspected choledocholithiasis: From guidelines to clinical practice. World J Gastrointest Endosc 2015; 7(2): 128-134 [PMID: 25685269 DOI: 10.4253/wjge.v7.i2.128]
Corresponding Author of This Article
Joana Magalhães, MD, Gastroenterology Department, Centro Hospitalar do Alto Ave, Rua dos Cutileiros, Creixomil, 4835-044 Guimarães, Portugal. jmagalhaes@chaa.min-saude.pt
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Magalhães J, Rosa B, Cotter J. Endoscopic retrograde cholangiopancreatography for suspected choledocholithiasis: From guidelines to clinical practice. World J Gastrointest Endosc 2015; 7(2): 128-134 [PMID: 25685269 DOI: 10.4253/wjge.v7.i2.128]
World J Gastrointest Endosc. Feb 16, 2015; 7(2): 128-134 Published online Feb 16, 2015. doi: 10.4253/wjge.v7.i2.128
Endoscopic retrograde cholangiopancreatography for suspected choledocholithiasis: From guidelines to clinical practice
Joana Magalhães, Bruno Rosa, José Cotter
Joana Magalhães, Bruno Rosa, José Cotter, Gastroenterology Department, Centro Hospitalar do Alto Ave, 4835-044 Guimarães, Portugal
José Cotter, Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, 4710-057 Braga, Guimarães, Portugal
José Cotter, ICVS/3B’s, PT Government Associate Laboratory, 4710-057 Braga, Guimarães, Portugal
Author contributions: Magalhães J participated in the design of the study, performed data analysis and literature research and drafted the manuscript; Rosa B performed literature research and critically revised the manuscript; Cotter J critically revised the manuscript and approved the final version to be submitted; all the authors read and approved the final manuscript.
Ethics approval: This study was approved by the institutional review board of Centro Hospitalar do Alto Ave, Guimarães, Portugal.
Informed consent: All patients provided written consent to undergo endoscopic retrograde cholangiopancreatography and were informed of the risks and potential benefits of the procedure.
Conflict-of-interest: The authors declare that there is no conflict of interests regarding the publication of this paper.
Data sharing: Technical appendix, statistical code, and dataset available from the corresponding author at jmagalhaes@chaa.min-saude.pt. The consent of the participants was not obtained but the presented data are anonymized and risk of identification is low.
Correspondence to: Joana Magalhães, MD, Gastroenterology Department, Centro Hospitalar do Alto Ave, Rua dos Cutileiros, Creixomil, 4835-044 Guimarães, Portugal. jmagalhaes@chaa.min-saude.pt
Telephone: +351-253-540330 Fax: +351-253-421308
Received: September 17, 2014 Peer-review started: September 20, 2014 First decision: October 14, 2014 Revised: December 14, 2014 Accepted: December 29, 2014 Article in press: December 31, 2014 Published online: February 16, 2015 Processing time: 147 Days and 17.8 Hours
Core Tip
Core tip: The American Society for Gastrointestinal Endoscopy (ASGE) proposes a stratification of patients according to the risk for choledocholithiasis, influencing subsequent management. Our study shown that the risk stratification, according to ASGE guidelines, may improve risk estimation of choledocholithiasis and should be considered to optimize patients’ selection for endoscopic retrograde cholangiopancreatography (ERCP). However, even in the “high risk group” the specificity was low. Thus, at this point, it seems advisable that also “high risk” patients undergo further testing before being submitted to ERCP, similarly to those patients with “intermediate risk”, while for patients with “low-risk” of choledocholithiasis a watchful waiting strategy seems adequate.
